Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

Dec 10, 2014

284_dirs_2014-12-10_35687d1c-86c7-4dab-b54d-539752942628.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-12-10

Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-10 Common Stock M 9333.0000 $35.0900 Acquired 353753.0630 Direct
2014-12-10 Common Stock M 3541.0000 $31.8400 Acquired 357294.0630 Direct
2014-12-10 Common Stock S 9846.0000 $60.0000 Disposed 347448.0630 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-10 Stock Option (right to buy) $31.8400 M 3541.0000 Disposed 2015-02-24 Common Stock (3541.0000) Direct
2014-12-10 Stock Option (right to buy) $35.0900 M 9333.0000 Disposed 2016-03-02 Common Stock (9333.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 3519.0523 Indirect

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: Includes shares acquired and dividends earned through October 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.

F4: The option became exercisable in equal installments on 2/25/2006, 2/25/2007 and 2/25/2008.

F5: The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009.